Luis A.Marcosa AnnieLeungb LauraKirkmanb Gary P.Wormserc
Tafenoquine is a highly effective treatment for Babesia microti infections in animal models. An immunocompromised patient infected by a strain of B. microti that was at least partially resistant to both azithromycin and atovaquone was treated with tafenoquine. Systematic clinical studies using tafenoquine for treating other patients with babesiosis should be considered.
Babesia, research, Treatment
Comments Off on Tafenoquine For Relapsing Babesiosis
Emerging Rodent-Associated Bartonella: A Threat For Human Health?
Mycotoxin/Chronic Illness Summit